SHSE:688656 (China)
Â
Class A
Â¥
116.92
+12.44 (+11.91%)
Sep 7
Business Description
HOB Biotech Group Corp Ltd
ISIN : CNE100004C37
Share Class Description:
SHSE:688656: Class ATotal Employee Number:
546Compare
Compare
Traded in other countries / regions
688656.China Index Membership
SSE Composite Index IPO Date
2021-01-13Description
HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.02 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 1.04 | |||||
Interest Coverage | 27.03 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 47.79 | |||||
Beneish M-Score | -2.68 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.8 | |||||
3-Year EBITDA Growth Rate | 4.4 | |||||
3-Year EPS without NRI Growth Rate | -26.9 | |||||
3-Year FCF Growth Rate | 82 | |||||
3-Year Book Growth Rate | 1.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.48 | |||||
9-Day RSI | 63.98 | |||||
14-Day RSI | 61.04 | |||||
3-1 Month Momentum % | -17.91 | |||||
6-1 Month Momentum % | -36.33 | |||||
12-1 Month Momentum % | -35.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.95 | |||||
Quick Ratio | 1.67 | |||||
Cash Ratio | 0.79 | |||||
Days Inventory | 239.01 | |||||
Days Sales Outstanding | 47.44 | |||||
Days Payable | 32.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.17 | |||||
Dividend Payout Ratio | 0.65 | |||||
3-Year Dividend Growth Rate | -17.3 | |||||
Forward Dividend Yield % | 0.17 | |||||
5-Year Yield-on-Cost % | 0.17 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 1.22 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59 | |||||
Operating Margin % | 6.23 | |||||
Net Margin % | 6.85 | |||||
EBITDA Margin % | 7.6 | |||||
FCF Margin % | 13.69 | |||||
OCF Margin % | 21.5 | |||||
ROE % | 3.36 | |||||
ROA % | 2.94 | |||||
ROIC % | 2.81 | |||||
3-Year ROIIC % | -8.58 | |||||
ROC (Joel Greenblatt) % | 3.91 | |||||
ROCE % | 3.7 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 265.73 | |||||
Forward PE Ratio | 123.08 | |||||
PE Ratio without NRI | 377.16 | |||||
Shiller PE Ratio | 132.86 | |||||
PS Ratio | 18.18 | |||||
PB Ratio | 8.93 | |||||
Price-to-Tangible-Book | 9.05 | |||||
Price-to-Free-Cash-Flow | 134.23 | |||||
Price-to-Operating-Cash-Flow | 85.54 | |||||
EV-to-EBIT | 240.38 | |||||
EV-to-EBITDA | 240.38 | |||||
EV-to-Revenue | 18.28 | |||||
EV-to-FCF | 133.51 | |||||
Price-to-GF-Value | 1.23 | |||||
Price-to-Projected-FCF | 40.32 | |||||
Price-to-Graham-Number | 12.32 | |||||
| Price-to-Net-Current-Asset-Value | 47.53 | |||||
Earnings Yield (Greenblatt) % | 0.42 | |||||
FCF Yield % | 0.75 | |||||
Forward Rate of Return (Yacktman) % | -24.57 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HOB Biotech Group Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 404.507 | ||
| EPS (TTM) (Â¥) | 0.44 | ||
| Beta | 1.4804 | ||
| 3-Year Sharpe Ratio | 0.55 | ||
| 3-Year Sortino Ratio | 2.37 | ||
| Volatility % | 58.8 | ||
| 14-Day RSI | 61.04 | ||
| 14-Day ATR (Â¥) | 6.572422 | ||
| 20-Day SMA (Â¥) | 96.5825 | ||
| 12-1 Month Momentum % | -35.54 | ||
| 52-Week Range (Â¥) | 76.62 - 217 | ||
| Shares Outstanding (Mil) | 63.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HOB Biotech Group Corp Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HOB Biotech Group Corp Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.200000 Cash Dividend | 2026-05-29 | 112.30 (-2.63%) | ||
| CNY 0.300000 Cash Dividend | 2025-05-29 | 87.85 (+0.13%) |
Show
Entries
HOB Biotech Group Corp Ltd Frequently Asked Questions
What is HOB Biotech Group Corp Ltd(SHSE:688656)'s stock price today?
The current price of SHSE:688656 is ¥116.92. The 52 week high of SHSE:688656 is ¥217.00 and 52 week low is ¥76.62.
When is next earnings date of HOB Biotech Group Corp Ltd(SHSE:688656)?
The next earnings date of HOB Biotech Group Corp Ltd(SHSE:688656) is .
Does HOB Biotech Group Corp Ltd(SHSE:688656) pay dividends? If so, how much?
The Dividend Yield %  of HOB Biotech Group Corp Ltd(SHSE:688656) is 0.17% (As of Today), Highest Dividend Payout Ratio of HOB Biotech Group Corp Ltd(SHSE:688656) was 1.3. The lowest was 0.25. And the median was 0.71. The  Forward Dividend Yield % of HOB Biotech Group Corp Ltd(SHSE:688656) is 0.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on HOB Biotech Group Corp Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers